-
Mashup Score: 2
Read about indications, safety, and warnings for VersaCross Steerable Access Solution.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4Exchangeless transseptal workflows for your mitral procedures - 13 hour(s) ago
Streamline your mitral procedural workflow with transseptal access solutions tailored to your needs.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Streamline your transseptal access workflow in your mitral procedures with VersaCross™ Steerable and Large Access Solutions. https://t.co/NVcWeInZPP #cardiotwitter #interventionalcardiology
-
-
Mashup Score: 8
Site Selective Pacing Catheters – Indications, Safety and Warnings
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Elevate your pacing procedures with Boston Scientific’s Conduction System Pacing portfolio. The INGEVITY™+ Pacing Lead, now with expanded LBBAP indication, allows precise navigation, efficient fixation, and continuous pacing. Safety info: https://t.co/fvTDG4nP2M
-
-
Mashup Score: 0Indications, safety, and warnings - VersaCross Connect™ Access Solution for FARADRIVE™ - 7 day(s) ago
Read about indications, safety, and warnings for VersaCross Connect™ Access Solution for FARADRIVE™.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Safety info: https://t.co/vTGPgOoGOA
-
-
Mashup Score: 4
VersaCross Connect™ Access Solution for FARADRIVE™ connects VersaCross™ technology with the FARADRIVE Steerable Sheath for zero exchange left heart access.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Streamline your FARAPULSE™ PFA System procedures: Connect VersaCross™ technology with the FARADRIVE™ Steerable Sheath for an integrated and predictable zero exchange left heart access workflow. Product info: https://t.co/1bNWc3G3R2 #EPeeps https://t.co/y8JoFKDWOJ
-
-
Mashup Score: 13Mapping Integration - FARAPULSE™ PFA System - 11 day(s) ago
Upon approval (anticipated 2024 2H), FARAPULSE will allow users to visualize their approach like never before. The FARAVIEW™ Software Module will offer integrated mapping to visualize catheter placement, shape and rotation of the magnetically-tracked FARAWAVE™ NAV Pulsed Field Ablation Catheter.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Unlike other modules that require manual intervention to differentiate shapes, FARAVIEW™ dynamically shows the shape, position, and rotation of the FARAWAVE™ NAV catheter and gives operators confidence in ablation applications. https://t.co/ZEDbBUoAAJ https://t.co/bg6tRdfUa2
-
-
Mashup Score: 1
FARAPULSE Pulsed Field Ablation System Indications, Safety and Warnings
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Safety Link: https://t.co/kOjiCrNzgI
-
-
Mashup Score: 6The OPTION Clinical Trial - 12 day(s) ago
The OPTION Clinical Trial is a randomized controlled trial comparing the safety and effectiveness of left atrial appendage closure (LAAC) to oral anticoagulation (OAC) therapy for stroke protection in post-ablation patients with atrial fibrillation. This study involves an investigational device called the WATCHMAN FLX™ *. The number of subjects expected to participate in the study will be 1600 at up to 130 investigational centers around the world. Below is an overview of the study. WATCHMAN FLX is an FDA
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
Mark your calendars! Results from the OPTION Clinical Trial, comparing the safety & effectiveness of the WATCHMAN FLX™ #LAAC device to oral anticoagulation for stroke protection post-ablation, will be presented at #AHA24. Learn more about OPTION: https://t.co/GX8J46fNTf https://t.co/wI6T0c9ghi
-
-
Mashup Score: 2AGENT™ Drug-Coated Balloon (DCB) - Boston Scientific - 15 day(s) ago
AGENT expands treatment options for in-stent restenosis (ISR). Designed to deliver a targeted anti-proliferative drug dose without adding extra layers of metal.
Source: www.bostonscientific.comCategories: General Medicine News, PayerTweet-
AGENT™ DCB consistently reduces 1-year TLF in patients with in-stent restenosis, regardless of sex, race, or vessel size. Learn more about AGENT™ DCB: https://t.co/P8woNXNg6X https://t.co/c1VPGqMDYj
-
-
Mashup Score: 4TCT 2024 - 17 day(s) ago
Join us at the Boston Scientific Engagement Hub at TCT 2024 for exclusive expert discussions, data-based learning, hands-on training, receptions and more.
Source: www.bostonscientific.comCategories: General Medicine News, Cardiology News and JournTweet-
Mark your calendar: Dr. Seun Alli will present insights on the HEAL-LAA study: WATCHMAN FLX™ Pro safety & efficacy tomorrow morning at #TCT2024. See more info here: https://t.co/JFgHh3Ab8s #Sponsored https://t.co/QhZgZD2UEa
-
Safety Info: https://t.co/ivs2ARHEj5